BeOne Medicines Ltd. (BEIGF)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 1,315,300 | - | - | - |
| Cost of sales - product-Product | 164,606 | - | - | - |
| Cost of sales - product | - | 165,002 | 170,462 | 138,132 |
| Total revenues | - | 1,117,279 | 1,001,599 | 929,166 |
| Gross profit | 1,150,694 | 952,277 | 831,137 | 791,034 |
| Selling, general and administrative | 537,913 | 459,288 | 455,223 | 443,729 |
| Research and development | 524,896 | 481,887 | 496,179 | 454,466 |
| Total operating expenses | 1,062,809 | 941,175 | 951,402 | 898,195 |
| Income (loss) from operations | 87,885 | 11,102 | -120,265 | -107,161 |
| Interest income, net | 3,497 | 5,848 | 10,643 | - |
| Other income (expense), net | 8,167 | 3,950 | 11,318 | -11,984 |
| Interest income, net | - | - | - | 13,225 |
| Income (loss) before income taxes | 99,549 | 20,900 | -98,304 | -105,920 |
| Income tax expense | 5,229 | 19,630 | 23,046 | 14,485 |
| Net income (loss) | 94,320 | 1,270 | -121,350 | -120,405 |
| Basic (in dollars per share) | 0.07 | - | -0.09 | -0.09 |
| Diluted (in dollars per share) | 0.06 | - | -0.09 | -0.09 |
| Weighted-average shares outstanding diluted (in shares) | 1,463,277,401 | 1,445,253,219 | 1,376,751,873 | 1,361,082,567 |
| Weighted-average shares outstandingbasic (in shares) | 1,408,166,754 | 1,390,052,966 | 1,376,751,873 | 1,361,082,567 |